Sagimet Biosciences Inc. (SGMT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sagimet Biosciences Inc.

    NASDAQ: SGMT · Real-Time Price · USD
    7.15
    0.01 (0.14%)
    At close: Sep 26, 2025, 1:15 PM

    Sagimet Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 2M n/a n/a
    Cost of Revenue
    		 n/a n/a 130K 134K
    Gross Profit
    		 n/a 2M -130K -134K
    Operating Income
    		 -54.45M -30.74M -31.05M -23.72M
    Interest Income
    		 n/a 2.86M 553K 26K
    Pretax Income
    		 -45.57M -27.88M -30.5M -24.44M
    Net Income
    		 -45.57M -27.88M -30.5M -24.44M
    Selling & General & Admin
    		 16.01M 12.96M 6.14M 4.38M
    Research & Development
    		 38.44M 19.78M 24.92M 19.34M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 54.45M 32.74M 31.05M 23.72M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 54.45M 32.74M 31.05M 23.72M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 31.35M 18.19M 22.17M 22.17M
    Shares Outstanding (Diluted)
    		 31.35M 18.19M 22.17M 22.17M
    EPS (Basic)
    		 -1.45 -1.53 -1.38 -1.1
    EPS (Diluted)
    		 -1.45 -1.53 -1.38 -1.1
    EBITDA
    		 -45.57M -30.74M -30.37M -24.31M
    EBIT
    		 -45.57M -30.74M -30.5M -24.44M
    Depreciation & Amortization
    		 n/a n/a 130K 134K

    Add to Watchlist